Work

Inhibiting PIM-1 Is Effective in Vitro and in Vivo against ALL: A Novel Mechanistic and Potentially Clinically Relevant Druggable Target.

Year: 2008

Type: article

Source: Blood

DOI: 10.1182/blood.v112.11.1922.1922

Authors: Valerie I. Brown, Cecilia Sheen, Jessica Hulitt, Theresa Ryan, Laura DiNardo, David Barrett, David T. Teachey, David J. Bearss, Gregory I. Berk, Stephan A. Grupp

Institutions: Children's Hospital of Philadelphia, University of Pennsylvania, SuperGen (United States)

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2570618841

FWCI:

Cites:

Cited by: 1

Related to: 10